Search Results

There are 14274 results for: content related to: Frontline treatment of localized osteosarcoma without methotrexate

  1. Influence of Age Upon Ifosfamide-Induced Nephrotoxicity

    Pediatric Blood & Cancer

    Volume 42, Issue 5, May 2004, Pages: 427–432, Jeannine S. McCune, Debra L. Friedman, Scott Schuetze, David Blough, Madonna Magbulos and Douglas S. Hawkins

    Version of Record online : 1 FEB 2004, DOI: 10.1002/pbc.20011

  2. You have free access to this content
    A study of 5 day fractionated ifosfamide pharmacokinetics in consecutive treatment cycles

    British Journal of Clinical Pharmacology

    Volume 42, Issue 2, August 1996, Pages: 179–186, LIONEL D. LEWIS

    Version of Record online : 2 OCT 2003, DOI: 10.1046/j.1365-2125.1996.03956.x

  3. You have free access to this content
    Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer

    Intervention Review

    The Cochrane Library

    Sebastiaan L Knijnenburg, Renée L Mulder, Antoinette YN Schouten-Van Meeteren, Arend Bökenkamp, Hester Blufpand, Eline van Dulmen-den Broeder, Margreet A Veening, Leontien CM Kremer and Monique WM Jaspers

    Published Online : 8 OCT 2013, DOI: 10.1002/14651858.CD008944.pub2

  4. You have free access to this content
    Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM

    British Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2000, Pages: 555–561, T. Kerbusch, A. D. R. Huitema, J. Ouwerkerk, H. J. Keizer, R. A. A. Mathôt, J. H. M. Schellens and J. H. Beijnen

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00217.x

  5. Investigation of ifosfamide nephrotoxicity induced in a liver–kidney co-culture biochip

    Biotechnology and Bioengineering

    Volume 110, Issue 2, February 2013, Pages: 597–608, Leila Choucha-Snouber, Caroline Aninat, Laurent Grsicom, Geoffrey Madalinski, Céline Brochot, Paul Emile Poleni, Florence Razan, Christiane Guguen Guillouzo, Cécile Legallais, Anne Corlu and Eric Leclerc

    Version of Record online : 28 AUG 2012, DOI: 10.1002/bit.24707

  6. You have free access to this content
    High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma

    Cancer

    Volume 100, Issue 8, 15 April 2004, Pages: 1724–1733, Kristine R. Crews, Tiebin Liu, Carlos Rodriguez-Galindo, Ming Tan, William H. Meyer, J. Carl Panetta, Michael P. Link and Najat C. Daw

    Version of Record online : 3 MAR 2004, DOI: 10.1002/cncr.20152

  7. Evaluation of ifosfamide salvage therapy for metastatic canine osteosarcoma

    Veterinary and Comparative Oncology

    Volume 12, Issue 4, December 2014, Pages: 249–257, K. Batschinski, N. G. Dervisis and B. E. Kitchell

    Version of Record online : 17 SEP 2012, DOI: 10.1111/j.1476-5829.2012.00355.x

  8. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  9. You have free access to this content
    A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer a cancer and leukemia group B study

    Cancer

    Volume 72, Issue 1, 1 July 1993, Pages: 62–68, Stephen L. Graziano, James E. Herndon II, Frederick Richards II, Santo Difino, Caron Modeas, David B. Duggan and Mark R. Green

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19930701)72:1<62::AID-CNCR2820720114>3.0.CO;2-E

  10. You have free access to this content
    Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood: A pediatric oncology group study

    Cancer

    Volume 72, Issue 5, 1 September 1993, Pages: 1790–1794, Mark L. Bernstein, V. Michael Whitehead, Susan Devine, Holcombe Grier, Faith Kung, Jeffrey Krischer, Zoanne Dreyer, Beverly Bell, Vita Land, George R. Buchanan and Charles Pratt

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19930901)72:5<1790::AID-CNCR2820720545>3.0.CO;2-4

  11. You have free access to this content
    Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma

    Cancer

    Volume 109, Issue 11, 1 June 2007, Pages: 2315–2322, Rashmi Chugh, Thomas Wagner, Kent A. Griffith, Jeremy M.G. Taylor, Dafydd G. Thomas, Francis P. Worden, Kirsten M. Leu, Mark M. Zalupski and Laurence H. Baker

    Version of Record online : 26 APR 2007, DOI: 10.1002/cncr.22669

  12. Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: A single hospital experience

    Medical and Pediatric Oncology

    Volume 27, Issue 3, September 1996, Pages: 145–148, Charles B. Pratt, Xiaolong Luo, Lei Fang, Neyssa Marina, Loraine Avery and Wayne L. Furman

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1096-911X(199609)27:3<145::AID-MPO2>3.0.CO;2-E

  13. You have free access to this content
    Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism.

    British Journal of Clinical Pharmacology

    Volume 30, Issue 5, November 1990, Pages: 725–732, LD Lewis, DL Fitzgerald, PG Harper and HJ Rogers

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1990.tb03842.x

  14. Risk Factors for Long-Term Outcome of Ifosfamide-Induced Nephrotoxicity in Children

    The Journal of Clinical Pharmacology

    Volume 39, Issue 5, May 1999, Pages: 454–461, Dr. Ronen Loebstein, Dr. Gordana Atanackovic, Dr. Raafat Bishai, Dr. Jacob Wolpin, Dr. Sohail Khattak, Mr. Goli Hashemi, Dr. Marcus Gobrial, Dr. Sylvian Baruchel, Dr. Shinya Ito and Dr. Gideon Koren

    Version of Record online : 8 MAR 2013, DOI: 10.1177/009127009903900504

  15. Modulation of the cytochrome P450–mediated metabolism of ifosfamide by ketoconazole and rifampin

    Clinical Pharmacology & Therapeutics

    Volume 70, Issue 2, August 2001, Pages: 132–141, Thomas Kerbusch, Rob L. H. Jansen, Ron A. A. Mathôt, Alwin D. R. Huitema, Myra Jansen, Ruud E. N. van Rijswijk and Jos H. Beijnen

    Version of Record online : 11 AUG 2001, DOI: 10.1067/mcp.2001.117283

  16. Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose

    Pediatric Blood & Cancer

    Volume 54, Issue 7, 1 July 2010, Pages: 983–989, Roderick Skinner, Annie Parry, Lisa Price, Michael Cole, Alan W. Craft and Andrew D.J. Pearson

    Version of Record online : 14 APR 2010, DOI: 10.1002/pbc.22364

  17. You have free access to this content
    Differential effects of ifosfamide on dendritic cell-mediated stimulation of T cell interleukin-2 production, natural killer cell cytotoxicity and interferon-γ production

    Clinical & Experimental Immunology

    Volume 153, Issue 3, September 2008, Pages: 429–438, M. C. Kuppner, E. Bleifuß, E. Noessner, R. Mocikat, C. von Hesler, C. Mayerhofer and R. D. Issels

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1365-2249.2008.03708.x

  18. Fanconi's Syndrome and Nephrogenic Diabetes Insipidus in an Adult Treated with Ifosfamide

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 1, January 2012, Pages: e12–e16, Amanda I. Ingemi, Vasile M. Bota, Anyeri Peguero and Margaret Charpentier

    Version of Record online : 4 JAN 2012, DOI: 10.1002/PHAR.1013

  19. Chronic ifosfamide nephrotoxicity in children

    Medical and Pediatric Oncology

    Volume 41, Issue 3, September 2003, Pages: 190–197, R. Skinner

    Version of Record online : 11 JUL 2003, DOI: 10.1002/mpo.10336

  20. You have free access to this content
    The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients.

    British Journal of Clinical Pharmacology

    Volume 31, Issue 1, January 1991, Pages: 77–82, LD Lewis, DL Fitzgerald, P Mohan, N Thatcher, PG Harper and HJ Rogers

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1991.tb03860.x